| Literature DB >> 30087732 |
Bilger Çavuş1, Özge Çaydaşı2, Ahmet Aktan3, Ercan Ayaz3.
Abstract
BACKGROUND: Brucellosis can lead to different clinical pictures such as hepatomegaly, granulomatous liver disease, hepatic abscess, and it can cause mild hepatic transaminase elevation in the laboratory investigations. CASE REPORT: We found out that the etiologic agent was Brucella in our two cases admitted with acute hepatitis presentation in the investigations conducted. Liver transaminases were as follows for case 1 and case 2; AST: 306/187U/L, ALT: 368/312U/L, ALP: 355/264U/L, GGT: 116/197U/L, LDH: 887/549U/L, respectively. Sacroiliitis also accompanied the clinical picture in our first case. Our patients showed clinical and laboratory improvement with rifampicin, doxycycline, (additional streptomycin for 21 days in the patient with sacroiliitis) treatment.Entities:
Keywords: Acute hepatitis; Brucellosis; Liver transaminases
Year: 2018 PMID: 30087732 PMCID: PMC6062275 DOI: 10.3889/oamjms.2018.198
Source DB: PubMed Journal: Open Access Maced J Med Sci ISSN: 1857-9655
Laboratory findings in the cases with brucellosis
| AST/ALT U/L | ALP/GGT U/L | LDH U/L | T.Bil/D.Bil mg/dL | INR/PTT(s) | WBC/NEU | HGB g/dL | PLT | CRP (mg/dL) | |
|---|---|---|---|---|---|---|---|---|---|
| CASE 1 Admission | 306/368 | 355/116 | 887 | 0.6/0.25 | 1.21/14 | 5000/2800 | 12.7 | 184000 | 1.89 |
| CASE 1 Treatment Second week | 79/119 | 267/104 | 633 | 0.3/0.1 | 1.17/13.5 | 6400/3500 | 12.2 | 410000 | 1.16 |
| CASE 1 End of Treatment | 22/34 | 180/98 | 330 | 0.4/0.1 | 1.14/13.1 | 6600/3300 | 13.1 | 300000 | 0.27 |
| CASE 1 Treatment protocol | Doxycycline 100 mg 2 x 1, Streptomycin 1 g 1x1 IM, Rifampicin 300 mg 1 x 2 were initiated. Doxycycline, Rifampicin treatment for six weeks, Streptomycin treatment for three weeks | ||||||||
| AST/ALT U/L | ALP/GGT U/L | LDH U/L | T.Bil/D.Bil mg/dL | INR/PTT(s) | WBC/NEU | HGB g/dL | PLT | CRP (mg/dL) | |
| CASE 2 Admission | 187/312 | 264/197 | 549 | 0.5/0.2 | 1.19/13.4 | 6000/4300 | 15.3 | 221000 | 1.45 |
| CASE 2 Treatment Second week | 106/298 | 162/129 | 253 | 0.4/0.2 | 1.16/13.4 | 4500/2.42 | 14.2 | 213000 | 1.12 |
| CASE 2 End of Treatment | 27/45 | 109/85 | 300 | 0.4/0.2 | 1.09/12.5 | 7000/4600 | 16.3 | 204000 | 0.6 |
| CASE 2 Treatment protocol | Doxycycline 100 mg 2 x 1, Rifampicin 300 mg 1 x 2 was completed in six weeks. | ||||||||